Aug 18 (Reuters) - Evolva Holding Sa EVE.S
* Entered into an agreement with private us biotech venture
to develop new production routes for existing active
pharmaceutical ingredients
* Later phases will potentially increase this to several
tens of millions of dollars in research and development funding
* Partnership does not change revenue guidance for 2016
* Will receive a low single digit million us dollar sum over
next 12 months
* Also receives a 20% equity stake in partner
Source text for Eikon: ID:nBw1Lj7Lna
Further company coverage: EVE.S
((Bangalore.newsroom@thomsonreuters.com;))